MiNK Therapeutics, Inc. (INKT) Tops Q2 EPS by 3c

MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q2 EPS of ($0.07), $0.03 better than the analyst estimate of ($0.10).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nutrien warns shareholders about below-market mini-tender offer
• Super League Enterprise (SLE) files for 1.07M share offering by selling stockholders